{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:51:38Z","timestamp":1790254298223,"version":"4.1.0"},"reference-count":34,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"DOI":"10.1210\/en.2017-00794","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T14:01:47Z","timestamp":1508767307000},"page":"260-271","source":"Crossref","is-referenced-by-count":39,"title":["Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis"],"prefix":"10.1210","volume":"159","author":[{"given":"Xiaodong","family":"Li","sequence":"first","affiliation":[{"name":"Amgen Inc., Thousand Oaks, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S","family":"Ominsky","sequence":"additional","affiliation":[{"name":"Amgen Inc., Thousand Oaks, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly S","family":"Villasenor","sequence":"additional","affiliation":[{"name":"Amgen Inc., Thousand Oaks, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Tian","family":"Niu","sequence":"additional","affiliation":[{"name":"Amgen Inc., Thousand Oaks, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J","family":"Asuncion","sequence":"additional","affiliation":[{"name":"Amgen Inc., Thousand Oaks, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuechun","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Physiological Sciences, University of Florida, Gainesville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Grisanti","sequence":"additional","affiliation":[{"name":"Amgen Inc., Thousand Oaks, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Wronski","sequence":"additional","affiliation":[{"name":"Department of Physiological Sciences, University of Florida, Gainesville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Scott","family":"Simonet","sequence":"additional","affiliation":[{"name":"Amgen Inc., Thousand Oaks, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua Zhu","family":"Ke","sequence":"additional","affiliation":[{"name":"UCB Pharma, Slough, Berkshire, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2017,10,20]]},"reference":[{"issue":"3","key":"2019041121514996100_B1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025","volume":"22","author":"Burge","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"1-2","key":"2019041121514996100_B2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","article-title":"Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)","volume":"8","author":"Hernlund","year":"2013","journal-title":"Arch Osteoporos"},{"key":"2019041121514996100_B3","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/9781118453926.ch62","volume-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"Orwoll","year":"2013","edition":"8th ed"},{"issue":"4","key":"2019041121514996100_B4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1210\/er.2008-0002","article-title":"Osteoporosis in men","volume":"29","author":"Khosla","year":"2008","journal-title":"Endocr Rev"},{"issue":"12","key":"2019041121514996100_B5","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1359\/jbmr.1997.12.12.2119","article-title":"Age-related (type II) femoral neck osteoporosis in men: biochemical evidence for both hypovitaminosis D- and androgen deficiency-induced bone resorption","volume":"12","author":"Boonen","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2019041121514996100_B6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-1-59745-104-8_9","article-title":"Orchidectomy models of osteoporosis","volume":"455","author":"Blouin","year":"2008","journal-title":"Methods Mol Biol"},{"issue":"3","key":"2019041121514996100_B7","first-page":"215","article-title":"Long-term effects of aging and orchidectomy on bone and body composition in rapidly growing male rats","volume":"1","author":"Ke","year":"2001","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"4","key":"2019041121514996100_B8","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1210\/endo.141.4.7408","article-title":"Lasofoxifene (CP-336,156), a selective estrogen receptor modulator, prevents bone loss induced by aging and orchidectomy in the adult rat","volume":"141","author":"Ke","year":"2000","journal-title":"Endocrinology"},{"issue":"48","key":"2019041121514996100_B9","doi-asserted-by":"crossref","first-page":"E5187","DOI":"10.1073\/pnas.1413828111","article-title":"Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels","volume":"111","author":"Chang","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"32","key":"2019041121514996100_B10","doi-asserted-by":"crossref","first-page":"26464","DOI":"10.1074\/jbc.M112.350108","article-title":"Characterization of the interaction of sclerostin with the low density lipoprotein receptor-related protein (LRP) family of Wnt co-receptors","volume":"287","author":"Holdsworth","year":"2012","journal-title":"J Biol Chem"},{"issue":"22","key":"2019041121514996100_B11","doi-asserted-by":"crossref","first-page":"19489","DOI":"10.1074\/jbc.M110.190330","article-title":"Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function","volume":"286","author":"Leupin","year":"2011","journal-title":"J Biol Chem"},{"issue":"20","key":"2019041121514996100_B12","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J Biol Chem"},{"issue":"29","key":"2019041121514996100_B13","doi-asserted-by":"crossref","first-page":"26770","DOI":"10.1074\/jbc.M504308200","article-title":"SOST is a ligand for LRP5\/LRP6 and a Wnt signaling inhibitor","volume":"280","author":"Sem\u00ebnov","year":"2005","journal-title":"J Biol Chem"},{"key":"2019041121514996100_B14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bone.2016.10.010","article-title":"Sclerostin deficiency in humans","volume":"96","author":"van Lierop","year":"2017","journal-title":"Bone"},{"issue":"6","key":"2019041121514996100_B15","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength","volume":"23","author":"Li","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2019041121514996100_B16","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1359\/jbmr.090411","article-title":"Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt\/beta-catenin signaling","volume":"24","author":"Lin","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2019041121514996100_B17","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1210\/er.2011-1060","article-title":"Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases","volume":"33","author":"Ke","year":"2012","journal-title":"Endocr Rev"},{"key":"2019041121514996100_B18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bone.2016.10.019","article-title":"Effects of sclerostin antibodies in animal models of osteoporosis","volume":"96","author":"Ominsky","year":"2017","journal-title":"Bone"},{"issue":"16","key":"2019041121514996100_B19","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"issue":"5","key":"2019041121514996100_B20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"2019041121514996100_B21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/jbmr.2396","article-title":"Sclerostin inhibition prevents spinal cord injury-induced cancellous bone loss","volume":"30","author":"Beggs","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2019041121514996100_B22","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/jbmr.2549","article-title":"Sclerostin antibody preserves the morphology and structure of osteocytes and blocks the severe skeletal deterioration after motor-complete spinal cord injury in rats","volume":"30","author":"Qin","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2019041121514996100_B23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/jbmr.1807","article-title":"Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading","volume":"28","author":"Spatz","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2019041121514996100_B24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bone.2010.09.009","article-title":"Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model","volume":"48","author":"Tian","year":"2011","journal-title":"Bone"},{"key":"2019041121514996100_B25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bone.2016.02.005","article-title":"Sclerostin antibody prevented progressive bone loss in combined ovariectomized and concurrent functional disuse","volume":"87","author":"Zhang","year":"2016","journal-title":"Bone"},{"issue":"5","key":"2019041121514996100_B26","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/jbmr.2776","article-title":"Sclerostin antibody treatment improves the bone phenotype of Crtap(\u2212\/\u2212) mice, a model of recessive osteogenesis imperfecta","volume":"31","author":"Grafe","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2019041121514996100_B27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jbmr.1717","article-title":"Sclerostin antibody improves skeletal parameters in a Brtl\/+ mouse model of osteogenesis imperfecta","volume":"28","author":"Sinder","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2019041121514996100_B28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2016.01.001","article-title":"Effect of anti-sclerostin therapy and osteogenesis imperfecta on tissue-level properties in growing and adult mice while controlling for tissue age","volume":"84","author":"Sinder","year":"2016","journal-title":"Bone"},{"issue":"3","key":"2019041121514996100_B29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jbmr.1803","article-title":"Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus","volume":"28","author":"Hamann","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2019041121514996100_B30","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/jbmr.2996","article-title":"Suppression of sclerostin alleviates radiation-induced bone loss by protecting bone-forming cells and their progenitors through distinct mechanisms","volume":"32","author":"Chandra","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2019041121514996100_B31","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1002\/jbmr.182","article-title":"Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats","volume":"25","author":"Li","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2019041121514996100_B32","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2019041121514996100_B33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2019041121514996100_B34","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jcph.239","article-title":"Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: a randomized, double-blind, placebo-controlled study","volume":"54","author":"Padhi","year":"2014","journal-title":"J Clin Pharmacol"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/159\/1\/260\/23201137\/en.2017-00794.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T11:46:11Z","timestamp":1555069571000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/159\/1\/260\/4560159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,20]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,10,20]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2017-00794","relation":{},"ISSN":["1945-7170"],"issn-type":[{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2017,10,20]]}}}